Dr. Simmons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6251 E Virginia Beach Blvd
Ste 200
Norfolk, VA 23502Phone+1 757-466-8683Fax+1 757-466-8892
Education & Training
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2010 - 2013
University of New England College of Osteopathic MedicineClass of 2010
Certifications & Licensure
VA State License 2010 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 91 citationsIdecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.Doris K Hansen, Surbhi Sidana, Lauren C Peres, Christelle Colin Leitzinger, Leyla Shune
Journal of Clinical Oncology. 2023-04-10 - 109 citationsCyclin-dependent kinase inhibitor therapy for hematologic malignanciesPrithviraj Bose, Gary Lee Simmons, Steven Grant
Expert Opinion on Investigational Drugs. 2013-05-25 - 35 citationsReal-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.Christopher J Ferreri, Michelle A T Hildebrandt, Hamza Hashmi, Leyla O Shune, Joseph P McGuirk
Blood Cancer Journal. 2023-08-09
Press Mentions
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 TrialMarch 2nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
